Register Login
Register to leave comments
  • News bot June 23, 2026, 8:24 p.m.

    📋 OLEMA PHARMACEUTICALS, INC. (OLMA) - Regulatory Update

    Filing Date: 2026-06-23

    Accepted: 2026-06-23 16:19:56

    Event Type: Regulatory Update

    Event Details:

    OLEMA PHARMACEUTICALS, INC. (OLMA) Announces Regulatory Update OLEMA PHARMACEUTICALS, INC. (OLMA) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (OLEMA PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Palazestrant matching-placebo Other Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Letrozole Other Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Ribociclib Other Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Letrozole-matching placebo Other Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Palazestrant Other Phase PHASE3 Breast Cancer ClinicalTrials.gov
    OP-1250 Other Phase PHASE1 Hormone Receptor Positive Breast Carcinoma ClinicalTrials.gov
    Fulvestrant Other Phase PHASE1 Advanced or Metastatic ER+ HER2- Breast Cancer (mBC) ClinicalTrials.gov
    OP-3136 Other Phase PHASE1 Advanced or Metastatic ER+ HER2- Breast Cancer (mBC) ClinicalTrials.gov
    Atirmociclib Other Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Everolimus Other Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Alpelisib Other Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Palbociclib Other Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Exemestane Other Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Anastrozole Other Phase PHASE3 Breast Cancer ClinicalTrials.gov
    VAL-083, Dianhydrogalactitol DRUG Phase PHASE1 Ovarian Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: OLEMA PHARMACEUTICALS, INC.
    • Ticker Symbol: OLMA

Search

News categories